文献速递湿疹皮炎与荨麻疹银屑病与炎症性皮肤病皮肤肿瘤

改变我们的微生物组:皮肤科中的益生菌

Changing our microbiome: probiotics in dermatology.
PubMed 文献 · Br J Dermatol · 2019-07-28

本综述检索PubMed与ClinicalTrials.gov,评估口服与外用益生菌在特应性皮炎、痤疮、银屑病、慢性伤口、脂溢性皮炎及皮肤肿瘤中的临床证据。除特应性皮炎外,相关临床试验较少;多数研究采用口服益生菌,外用者少含皮肤共生菌。总体结果显示益生菌干预后皮肤状况改善,但需更多研究证实。

要点

  • 除特应性皮炎外,益生菌用于皮肤病防治的临床试验较少。
  • 多数研究为口服益生菌,外用益生菌研究少且多不含皮肤共生菌。
  • 现有临床试验总体显示益生菌干预后皮肤状况改善。

核心结论

  • 口服与外用益生菌对某些炎症性皮肤病似乎有效,在伤口愈合和皮肤癌中显示有前景的作用。
  • 但需要更多研究来证实这些结果。

研究设计与样本

  • 综述检索PubMed和ClinicalTrials.gov数据库中关于皮肤微生物组差异及益生菌在特应性皮炎、痤疮、银屑病、慢性伤口、脂溢性皮炎和皮肤肿瘤患者中作用的基础科学、转化研究和临床研究。

主要发现

  • 除特应性皮炎外,探索益生菌用于皮肤病预防和治疗的临床试验很少。
  • 多数研究调查口服益生菌干预,使用外用益生菌的研究中很少包含皮肤共生菌。
  • 总体而言,现有临床试验在益生菌干预后皮肤状况改善方面产生了阳性结果。

临床怎么用

  • 口服和外用益生菌可能用于某些炎症性皮肤病的治疗,并在伤口愈合和皮肤癌中显示有前景的作用。
  • 临床决策需考虑现有证据有限,需更多研究证实。

局限性

  • 除特应性皮炎外,相关临床试验较少。
  • 多数研究为口服益生菌,外用益生菌研究少且多不含皮肤共生菌。
  • 需要更多研究证实现有结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Commensal bacteria are a major factor in human health and disease pathogenesis. Interest has recently expanded beyond the gastrointestinal microbiome to include the skin microbiome and its impact on various skin diseases. OBJECTIVES: Here we present current data reviewing the role of the microbiome in dermatology, considering both the gut and skin microflora. Our objective was to evaluate whether the clinical data support the utility of oral and topical probiotics for certain dermatological diseases. METHODS: The PubMed and ClinicalTrials.gov databases were searched for basic science, translational research and clinical studies that investigated differences in the cutaneous microbiome and the impact of probiotics in patients with atopic dermatitis, acne vulgaris, psoriasis, chronic wounds, seborrhoeic dermatitis and cutaneous neoplasms. RESULTS: Few clinical trials exist that explore the utility of probiotics for the prevention and treatment of dermatological diseases, with the exception of atopic dermatitis. Most studies investigated oral probiotic interventions, and of those utilizing topical probiotics, few included skin commensals. In general, the available clinical trials yielded positive results with improvement of the skin conditions after probiotic intervention. CONCLUSIONS: Oral and topical probiotics appear to be effective for the treatment of certain inflammatory skin diseases and demonstrate a promising role in wound healing and skin cancer. However, more studies are needed to confirm these results. What's already known about this topic? The microbiome plays a role in human health and disease pathogenesis. Probiotics can manipulate the host microbiome and may confer health benefits for patients. Research to date has already begun to explore the utility of oral and topical probiotics for certain dermatological diseases. What does this study add? This review presents basic science and clinical trial data to support the role of the gut and skin microbiome in dermatology. Current data are reviewed on the use of probiotics in the prevention and treatment of skin diseases, including atopic dermatitis, acne vulgaris, psoriasis, seborrhoeic dermatitis, chronic wounds and cutaneous neoplasms. Future probiotic interventions are proposed.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Yu Y, Dunaway S, Champer J, et al. Changing our microbiome: probiotics in dermatology. Br J Dermatol. 2019. PMID: 31049923. doi:10.1111/bjd.18088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。